Giving Guide Centers & Institutes Sidney Kimmel Cancer Center MRIE Recent Publications Recent Publications Make a Gift 2022 Publications Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial IGF1R inhibition enhances the therapeutic effects of Gq/11 inhibition in metastatic uveal melanoma progression Pyruvate dehydrogenase inactivation causes glycolytic phenotype in BAP1 mutant uveal melanoma
